徐诺药业 Revenue and Competitors

Dover, DE USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • 徐诺药业's estimated annual revenue is currently $3M per year.(i)
  • 徐诺药业's estimated revenue per employee is $201,000

Employee Data

  • 徐诺药业 has 15 Employees.(i)
  • 徐诺药业 grew their employee count by -6% last year.

徐诺药业's People

NameTitleEmail/Phone
1
Chairman, CEO & PresidentReveal Email/Phone
2
Chief Development Officer and EVP QualityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$34M1698%N/AN/A
#2
$8.4M42-28%N/AN/A
#3
$68.7M3426%N/AN/A
#4
$49.4M246-10%N/AN/A
#5
$7.8M3944%N/AN/A
#6
$148.3M7388%N/AN/A
#7
$24.7M12313%N/AN/A
#8
$0.8M814%N/AN/A
#9
$9M457%N/AN/A
#10
$3.8M19-50%N/AN/A
Add Company

What Is 徐诺药业?

Xynomic Pharmaceuticals, Inc. is a US incorporated biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies. Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner. Xynomic Pharma is headquartered in the Shanghai with major operations in US and Shanghai, China.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15-6%N/A
#2
$1.6M150%N/A
#3
$1.3M150%N/A
#4
$3.6M150%N/A
#5
$1.4M1645%N/A